If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksICG Enterprise Trust Regulatory News (ICGT)

Share Price Information for ICG Enterprise Trust (ICGT)

Share Price is delayed by 15 minutes
Get Live Data
1,404.00    -10.00 (-0.71%)
Bid:
1,404.00
Ask:
1,422.00
Spread: 18.00 (1.282%)
Market Cap: £854.20m
ICGT Live PriceLast checked at - London Stock Exchange

Intraday ICG Enterprise Trust Share Chart

Kepler Trust Intelligence: New Research

24 Jan 2019 09:18

RNS Number : 9981N
ICG Enterprise Trust PLC
24 January 2019
 

ICG Enterprise Trust: New research

24/01/2018

· Differentiated access to an asset class that continues to outperform

 

Read more

Market volatility, concerns around a trade war and worries over a slowing global economy have led to falls in markets during the latter half of 2018. Market sentiment has clearly changed since the summer. In the world of investment trusts this has led to discounts widening. The listed private equity sector has shared in this, but no-where has this de-rating been more heavily felt than in the fund of fund sub-sector. Discounts have widened considerably this year, but most especially from the position in May 2018. 

In the case of ICG Enterprise, the discount has widened from 9% in May 2018 to 21% at the end of December 2018 - yet the portfolio continues to perform and fundamentals of the drivers of ICG Enterprise's returns remain unchanged. With an approach that has produced strong returns through the cycle, we take a closer look at the trust which moved to appoint ICG as manager three years ago.

The investment team believe the trust's strategy provides shareholders with the "best of both worlds" in terms of having a relatively concentrated investment portfolio, with the diversification benefits of a third-party funds portfolio.

The managers' choice of ICG as a home nearly three years ago is relevant at the current stage in the economic cycle. ICG's flagship funds are aiming for private equity type returns, but with lower volatility. The team aims to increase what they term "high conviction" investments - co-investments and ICG originated deals - where they (or the wider ICG investment team) has made the investment decision to invest in the underlying company.

Indeed, the team have increased their deployment rate into co-investments to c. 2.5% of NAV per investment (versus c.1% whilst at Graphite). We expect the top 30 holdings to increase to perhaps 55-60% of NAV (currently 47%). Over the past 12 months 39% of all capital deployed has been invested in and alongside ICG as the team take advantage of the proprietary deal flow the trust now benefits from.

Given the backdrop of the past year or so, the team believe that a highly selective approach is key and remain cautious. As such, and across the portfolio and the recent investments, three themes dominate. The team have been investing in companies which in their view exhibit defensive growth (recurring revenue, quality earnings, barriers to entry), structural downside protection (including investing in the debt and equity of deals), and relative value(where deal dynamics has facilitated investment at very attractive valuations).

Click here to read the full report

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Important information

ICG Enterprise Trust is a client of Kepler Trust Intelligence. This material should be considered a marketing communication, and is not independent research.

Kepler Partners is not authorised to make recommendations to Retail Clients. This report is based on factual information only, and is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

This report has been issued by Kepler Partners LLP solely for information purposes only and the views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment. If you are unclear about any of the information on this website or its suitability for you, please contact your financial or tax adviser, or an independent financial or tax adviser before making any investment or financial decisions.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. Persons who access this information are required to inform themselves and to comply with any such restrictions. In particular, this website is exclusively for non-US Persons. The information in this website is not for distribution to and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America to or for the benefit of US Persons.

This is a marketing document, should be considered non-independent research and is subject to the rules in COBS 12.3 relating to such research. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research.

No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not to be taken as advice to take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's conflict of interest policy is available on request.

Past performance is not necessarily a guide to the future. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that Independent financial advice should be taken before entering into any financial transaction.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is a limited liability partnership registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority.

 

 

About this service

Kepler Trust Intelligence for private investors is not just another news and research website. Our aim is to create a library of high quality investment strategy research, fund analysis and useful guides for private investors, all written in-house by experienced analysts on the investment companies team at Kepler Partners.

We are focused entirely on investment trusts, however we believe that it helps to understand them better if they are placed on a level playing field with OEICs, so you will see comparisons between the two in these pages often.

 

Our content falls into three categories;

Investment strategy articles are designed to highlight opportunities and developments which are of interest to investment trust investors, positive or negative.

Fund research focuses on individual trusts, examining them in detail to create a snapshot picture which you can use to decide whether or not you want to invest in them.

Educational output is split into simple guides, designed to help beginners understand how investment trusts work, and more complex guides to sectors, regions and strategies which may be of interest to investors.

We do not produce massive amounts of research. Our focus is on quality, not quantity, so we are unlikely to publish more than four or five articles in a given week. For this reason we recommend that you join our mailing list, and we'll send you an email once a week alerting you to what's new on the site. We won't sell your details, and we won't spam you with useless updates.

 

How are we funded?

Kepler Trust Intelligence is funded entirely by the providers of investment trusts, and is made available freely to any person (professional or private individual) who wants to access it. We clearly disclose all of our relationships, but our research is either paid for directly by specific trusts and their boards, or more generally by the larger asset management groups who pay to have adverts and advertorial. As a result, all of our research should be considered "non-independent" and readers should consider it as marketing.

All of our content is freely available to anyone. We run two versions of the site - one for professionals and one for private investors. The professional site requires readers to volunteer the name of the company they work for and the city / region - so that from a compliance perspective we can be satisfied that all readers really are a professional.

 

We provide information, not advice

While we hope that you find the research we publish useful, and we believe it will help you to make a more informed decision, but we must of course stress that none of the research published here constitutes a recommendation, or advice, and you should not think that - just because we've published a report on a trust - we believe that trust is a 'buy'. Please read our terms and conditions.

 

If you want to manage your own investments we hope that this website is a useful source of information which helps you to do that, however if you are in any doubt, you should speak to a financial adviser.

 

Pascal Dowling

 

Kepler Partners

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEANFLAFLNEEF
Date   Source Headline
3rd Jul 20139:56 amRNSHolding(s) in Company
26th Jun 20139:46 amRNSDirector/PDMR Shareholding
19th Jun 20132:51 pmRNSDirectorate Change
14th Jun 20133:18 pmRNSResult of AGM
13th Jun 20131:30 pmRNSInterim Management Statement
29th May 20131:24 pmRNSDisposal of Dominion Gas
13th May 20134:14 pmRNSDirector/PDMR Shareholding
18th Apr 20131:00 pmRNSAnnual Financial Report
17th Apr 201311:17 amRNSAnnouncement regarding Listing Rule 9.6.14
5th Apr 201312:58 pmRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSUnaudited results for the year ended January 2013
27th Mar 20134:20 pmRNSAppointment of non-executive director
27th Mar 20134:14 pmRNSHolding(s) in Company
19th Dec 20125:01 pmRNSAudit committee appointment
6th Dec 20127:00 amRNSInterim Management Statement
26th Oct 20123:22 pmRNSAnnouncement in accordance with LR 9.6.14
5th Oct 201211:01 amRNSDisposal of NES Group
28th Sep 20127:00 amRNSHalf Yearly Report to 31 July
10th Jul 20123:47 pmRNSAudit committee appointment
22nd Jun 201212:18 pmRNSDirector/PDMR Shareholding
18th Jun 20124:11 pmRNSDirector/PDMR Shareholding
18th Jun 20127:00 amRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSAGM Statement
11th Jun 20122:12 pmRNSInterim Management Statement 30 April 2012
28th May 201211:53 amRNSAnnual Information Update
9th May 20124:58 pmRNSAnnual Financial Report 31 Jan 2012
5th Apr 20127:00 amRNSFinal Results for the year ended 31 January 2012
27th Mar 20121:22 pmRNSAnnouncement re LR 9.6.13
30th Jan 201211:15 amRNSDirector/PDMR Shareholding
8th Dec 20117:00 amRNSInterim Management Statement
21st Nov 20111:03 pmRNSHolding(s) in Company
7th Oct 201111:58 amRNSIncrease in bank facility to £60 million
26th Sep 20117:00 amRNSHalf Yearly Report
22nd Jul 201112:14 pmRNSNOTIFICATION IN ACCORDANCE WITH LR 9.6.14
18th Jul 201111:30 amRNSDirector/PDMR Shareholding
14th Jul 20113:11 pmRNSDirectorate Change
24th Jun 20112:32 pmRNSDirector/PDMR Shareholding
16th Jun 20111:35 pmRNSAGM Statement 2011
15th Jun 201111:14 amRNSInterim Management Statement
2nd Jun 20112:04 pmRNSDisposal of Kurt Geiger
18th May 20115:24 pmRNSAnnual Information Update
19th Apr 20119:55 amRNSDirectorate update
18th Apr 20114:39 pmRNSAnnual Financial Report
14th Apr 20114:14 pmRNSDirectorate Change
8th Apr 201112:03 pmRNSDisposal
5th Apr 20119:51 amRNSDirector/PDMR Shareholding
4th Apr 20117:00 amRNSFinal Results for the period to 31 January 2011
29th Mar 20117:00 amRNSNotice of Results
25th Mar 20117:00 amRNSDisposal
22nd Mar 20113:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.